Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for…

Overview of attention for article published in Biology of Blood & Marrow Transplantation, August 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#31 of 3,759)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 3 news outlets
twitter: 55 X users

patent: 1 patent
guideline: 2 clinical guideline sources

Readers on

mendeley: 187 Mendeley

So far, Altmetric has seen 65 X posts from 55 X users, with an upper bound of 161,590 followers.

New article: Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and… https://t.co/i2tbyNHQoK #MMSM #Mul…

RT @HemaClinicoVLC: 🔖 Use of CAR-T Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma https://t.c…

🔖 Use of CAR-T Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma https://t.co/xCZ06kAiZV @sehh @GETH_info @TheEBMT #cart #lymphoma

Thanks for shout out @JayaniReena looking forward to future collaborations:)

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 61 additional X posts.